Findings observed among adults with mild or moderate COVID-19
Microarray Skin Patch Successfully Delivers Measles Vaccines
The journal Vaccines recently reported that microarray patches (MAPs) have the potential to be a safer, more acceptable, easier-to-use, and more cost-effective means for the administration of vaccines than injection by needle and syringe.
COVID-19 Vaccination Before Infection Cuts Risk for Long COVID
COVID-19 vaccination with any number of doses before infection linked to reduced risk for post-COVID-19 condition
Mpox Outbreaks Continue in Late 2023
The World Health Organization (WHO) today reported that the multi-country mpox outbreak continues at a low transmission level in the European Region and the Americas.
The 30th WHO Situation Report, published on November 25, 2023, offers insights regarding the latest epidemiology and a particular focus on the ongoing and evolving epidemiology of mpox in the Democratic Republic of the Congo (DRC).
Incidence of Local-Stage Cancers Decreased From 2019 to 2022
Incidence decreased significantly for 19 of 22 cancer types, deviating from stable year-over-year changes pre-COVID-19
COVID-19 Pandemic Had Negative Impact on Bone Health in Young Adults
During the pandemic, speed of sound was significantly lower along length of forearm radius bone
People With Severe Mental Illness Experienced Increased COVID-19 Mortality
Risk for death was found to be exacerbated by comorbidities
Enhanced Influenza Vaccine Protects Children Best
New real-world data focused on cell-based quadrivalent seasonal influenza vaccine (QIVc) was recently published in the journal Vaccines.
This CSL Seqirus-funded study evaluated data from 16 studies over four flu seasons and is the latest to underscore the measurable value of QIVc or the relative VE (rVE) for children compared to older egg-based QIV (QIVe) vaccines.
Enhanced Influenza Vaccine Protects Children Best
New real-world data focused on cell-based quadrivalent seasonal influenza vaccine (QIVc) was recently published in the journal Vaccines.
This CSL Seqirus-funded study evaluated data from 16 studies over four flu seasons and is the latest to underscore the measurable value of QIVc or the relative VE (rVE) for children compared to older egg-based QIV (QIVe) vaccines.
Mammals Consuming Sick Birds Become Infected with Avian Influenza
New research highlights multiple detections of Highly Pathogenic Avian Influenza (HPAI) A(H5N1) virus Eurasian lineage H5 clade 2.3.4.4b in wild terrestrial mammals in the United States.
This finding, published by the U.S. CDC Emerging Infectious Diseases Volume 29, Number 12—December 2023, builds on previous reports of natural infections with HPAI virus in red foxes and adds to the global list of species susceptible to H5N1 HPAI virus.